Correlation Between Oncorus and Navidea Biopharmaceutica
Can any of the company-specific risk be diversified away by investing in both Oncorus and Navidea Biopharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncorus and Navidea Biopharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncorus and Navidea Biopharmaceuticals, you can compare the effects of market volatilities on Oncorus and Navidea Biopharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncorus with a short position of Navidea Biopharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncorus and Navidea Biopharmaceutica.
Diversification Opportunities for Oncorus and Navidea Biopharmaceutica
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Oncorus and Navidea is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Oncorus and Navidea Biopharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Navidea Biopharmaceutica and Oncorus is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncorus are associated (or correlated) with Navidea Biopharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Navidea Biopharmaceutica has no effect on the direction of Oncorus i.e., Oncorus and Navidea Biopharmaceutica go up and down completely randomly.
Pair Corralation between Oncorus and Navidea Biopharmaceutica
If you would invest (100.00) in Navidea Biopharmaceuticals on December 29, 2024 and sell it today you would earn a total of 100.00 from holding Navidea Biopharmaceuticals or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Oncorus vs. Navidea Biopharmaceuticals
Performance |
Timeline |
Oncorus |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Navidea Biopharmaceutica |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Oncorus and Navidea Biopharmaceutica Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Oncorus and Navidea Biopharmaceutica
The main advantage of trading using opposite Oncorus and Navidea Biopharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncorus position performs unexpectedly, Navidea Biopharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Navidea Biopharmaceutica will offset losses from the drop in Navidea Biopharmaceutica's long position.Oncorus vs. Apollomics Class A | Oncorus vs. Pyxis Oncology | Oncorus vs. Zura Bio Limited | Oncorus vs. Elevation Oncology |
Navidea Biopharmaceutica vs. NovaBay Pharmaceuticals | Navidea Biopharmaceutica vs. Cyclacel Pharmaceuticals | Navidea Biopharmaceutica vs. Tenax Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
Commodity Directory Find actively traded commodities issued by global exchanges | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |